Classification
- Anatomical main groupNNervous system
- Therapeutic subgroupN05
- Pharmacological subgroupN05A
- Chemical subgroupN05AE
- Chemical substanceN05AE05Lurasidone
Where it is registered
Each register with its number of medicines and a few of them.
Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Anvisa · 10 medicines
ALIMS · 9 medicines
CBG-MEB · 6 medicines
AIFA · 5 medicines
SFDA · 5 medicines · Historical list
HSA · 5 medicines
HALMED · 4 medicines
MS · 3 medicines · Historical list
FDA · 2 medicines
Every register, a page at a time. Strengths and packs are on each medicine’s page.
107 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Lurasidone | Canada | 40 MG | Tablet | Marketed | Sanis Health INC |
| Lurasidone | Canada | 20 MG | Tablet | Marketed | Sanis Health INC |
| Lurasidone | Canada | 80 MG | Tablet | Marketed | Sanis Health INC |
| Lurasidone | Canada | 60 MG | Tablet | Marketed | Sanis Health INC |
| Lurasidone | Canada | 120 MG | Tablet | Authorised | Sanis Health INC |
| Lurasidone Doc | Italy | Compressa rivestita con film | Authorised | Doc Generici SRL | |
| Lurasidone Teva | Italy | Compressa rivestita con film | Authorised | Teva B.V. | |
| Lurasidone Accord | Italy | Compressa rivestita con film | Authorised | Accord Healthcare, S.L.U. | |
| Lurasidone Liconsa | Italy | Compressa rivestita con film | Authorised | Laboratorios Liconsa, S.A. | |
| Lurasidone Hydrochloride | United States | 120MG, 20MG, 40MG … | tablet | Marketed | MSN |
| Nra-Lurasidone | Canada | 80 MG | Tablet | Marketed | Nora Pharma INC |
| Nra-Lurasidone | Canada | 60 MG | Tablet | Marketed | Nora Pharma INC |
| Nra-Lurasidone | Canada | 40 MG | Tablet | Marketed | Nora Pharma INC |
| Nra-Lurasidone | Canada | 20 MG | Tablet | Marketed | Nora Pharma INC |
| PMS-Lurasidone | Canada | 40 MG | Tablet | Marketed | Pharmascience INC |
| PMS-Lurasidone | Canada | 120 MG | Tablet | Marketed | Pharmascience INC |
| PMS-Lurasidone | Canada | 20 MG | Tablet | Marketed | Pharmascience INC |
| PMS-Lurasidone | Canada | 60 MG | Tablet | Marketed | Pharmascience INC |
| PMS-Lurasidone | Canada | 80 MG | Tablet | Marketed | Pharmascience INC |
| Auro-Lurasidone | Canada | 80 MG | Tablet | Marketed | Auro Pharma INC |
| Auro-Lurasidone | Canada | 20 MG | Tablet | Marketed | Auro Pharma INC |
| Auro-Lurasidone | Canada | 120 MG | Tablet | Marketed | Auro Pharma INC |
| Auro-Lurasidone | Canada | 40 MG | Tablet | Marketed | Auro Pharma INC |
| Auro-Lurasidone | Canada | 60 MG | Tablet | Marketed | Auro Pharma INC |
| Jamp Lurasidone | Canada | 120 MG | Tablet | Marketed | Jamp Pharma Corporation |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.